Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q1 | $1.2B | -- | -- | $1.28 | -- |
| 12/18/2025 | Q4 | $1.2B | $1.2B | $1.34 | $1.22 | $0.12 |
| 08/25/2025 | Q3 | $1.1B | $1.1B | $1.26 | $1.14 | $0.12 |
| 05/29/2025 | Q2 | $1.1B | $1.1B | $1.12 | $1.03 | $0.08 |
| 02/26/2025 | Q1 | $983.5M | $1B | $1.20 | $0.95 | $0.24 |
| 12/18/2024 | Q4 | $1B | $1B | $0.99 | $0.98 | $0.02 |
| 08/26/2024 | Q3 | $993.9M | $992.2M | $0.97 | $0.92 | $0.05 |
| 05/28/2024 | Q2 | $951.9M | $955.4M | $0.88 | $0.82 | $0.06 |
| 02/26/2024 | Q1 | $891.7M | $896.4M | $0.82 | $0.73 | $0.09 |
| 12/18/2023 | Q4 | $899.4M | $936.4M | $0.74 | $0.69 | $0.05 |
| 08/28/2023 | Q3 | -- | $722.9M | $0.74 | -- | -- |
| 05/22/2023 | Q2 | -- | $687.8M | $0.76 | -- | -- |
| 02/27/2023 | Q1 | -- | $620.9M | $0.67 | -- | -- |
| 12/19/2022 | Q4 | -- | $609.6M | $0.70 | -- | -- |
| 08/30/2022 | Q3 | -- | $569.5M | $0.60 | -- | -- |
| 05/23/2022 | Q2 | -- | $538.8M | $0.62 | -- | -- |
| 02/23/2022 | Q1 | -- | $490.3M | $0.63 | -- | -- |
| 12/16/2021 | Q4 | -- | $509.4M | $0.62 | -- | -- |
| 08/24/2021 | Q3 | -- | $471.7M | $0.56 | -- | -- |
| 05/25/2021 | Q2 | -- | $466.7M | $0.51 | -- | -- |
| 02/23/2021 | Q1 | -- | $417.9M | $0.51 | -- | -- |
| 12/21/2020 | Q4 | -- | $426.2M | $0.45 | -- | -- |
| 08/26/2020 | Q3 | -- | $386.4M | $0.40 | -- | -- |
| 05/26/2020 | Q2 | -- | $468.1M | $0.55 | -- | -- |
| 02/25/2020 | Q1 | -- | $506.3M | $0.89 | -- | -- |
| 12/16/2019 | Q4 | -- | $541.5M | $0.62 | -- | -- |
| 08/27/2019 | Q3 | -- | $532.3M | $0.59 | -- | -- |
| 05/28/2019 | Q2 | -- | $515.6M | $0.60 | -- | -- |
| 02/26/2019 | Q1 | -- | $466.1M | $0.58 | -- | -- |
| 12/17/2018 | Q4 | -- | $476.9M | $0.49 | -- | -- |
| 08/27/2018 | Q3 | -- | $465.8M | $0.49 | -- | -- |
| 05/29/2018 | Q2 | -- | $430.6M | $0.44 | -- | -- |
| 02/27/2018 | Q1 | -- | $404.4M | $0.48 | -- | -- |
| 12/18/2017 | Q4 | -- | $421.2M | $0.40 | -- | -- |
| 08/23/2017 | Q3 | -- | $391.5M | $0.34 | -- | -- |
| 05/23/2017 | Q2 | -- | $368.7M | $0.34 | -- | -- |
| 02/28/2017 | Q1 | -- | $343.4M | $0.30 | -- | -- |
| 12/13/2016 | Q4 | -- | $363.3M | $0.33 | -- | -- |
| 08/25/2016 | Q3 | -- | $356.1M | $0.32 | -- | -- |
| 05/25/2016 | Q2 | -- | $350.6M | $0.29 | -- | -- |
| 02/25/2016 | Q1 | -- | $306.2M | $0.24 | -- | -- |
HEICO Corp. reported $1.2B worth of top line sales in its most recent quarter.
HEICO Corp. announced earnings per share of $1.34 which represents a beat of analyst forecast a $1.22 per share.
HEICO Corp. reported $518.5M that represents $3.68 per share over the last quarter.
HEICO Corp.'s earnings are forecast to grow from $4.90 per share to $4.79 per share next year representing an increase of 13.37%.
HEICO Corp.'s next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.